Literature DB >> 8611479

Molecular characterization of the 7q deletion in myeloid disorders.

S Lewis1, G Abrahamson, J Boultwood, C Fidler, A Potter, J S Wainscoat.   

Abstract

Deletion of the long arm of chromosome 7 is a common karyotypic finding in myeloid disorders and in particular is found in association with secondary leukaemias. We have used restriction fragment length polymorphisms and gene dosage experiments to assess the loss or retention of sequences localized to chromosome 7q in five patients with clonal myeloid disorders and a 7q deletion. The deletion was interstitial in all cases with retention of the anonymous marker pS194 located at 7q36-qter. Three out of five cases also retained the more proximal gene T-cell receptor beta (TCR beta) located at 7q35. The proximal breakpoints of all five cases were localized to 7q22 by cytogenetic analysis. In two cases the proximal breakpoint lay between the genes for elastin (ELN) and collagen type 1 alpha (COL1A2) and in three cases distal to this region between the genes for erythropoietin (EPO) and acetylcholinesterase (ACHE). The genes of ACHE, plasminogen activator inhibitor 1 (PLANH1), CCAAT displacement protein (CUTL1) and Met proto-oncogene (MET) were deleted in all cases. Molecular analysis of the 7q deletion in myeloid leukaemias demonstrates heterogeneity of the breakpoints, supporting a recessive mechanism of tumourigenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8611479     DOI: 10.1046/j.1365-2141.1996.4841025.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

2.  DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype.

Authors:  Eigil Kjeldsen; Christopher Veigaard
Journal:  Cell Oncol (Dordr)       Date:  2013-08-27       Impact factor: 6.730

3.  Telomerase activity in human leukemic cells with or without monosomy 7 or 7q-.

Authors:  Nedime Serakinci; Jørn E Koch
Journal:  BMC Med Genet       Date:  2002-10-29       Impact factor: 2.103

4.  Case Report: Congenital Brain Dysplasia, Developmental Delay and Intellectual Disability in a Patient With a 7q35-7q36.3 Deletion.

Authors:  Liang-Liang Fan; Yue Sheng; Chen-Yu Wang; Ya-Li Li; Ji-Shi Liu
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

5.  Inversion of chromosome 7q22 and q36 as a sole abnormality presenting in myelodysplastic syndrome: a case report.

Authors:  Hiroto Kaneko; Kazuho Shimura; Saeko Kuwahara; Muneo Ohshiro; Yasuhiko Tsutsumi; Toshiki Iwai; Shigeo Horiike; Shouhei Yokota; Yasuo Ohkawara; Masafumi Taniwaki
Journal:  J Med Case Rep       Date:  2014-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.